Terra Catalyst Fund (DI)

TCF:LNLondon Stock Exchange

Latest Coverage

Research • 28 Sept 2026

Capital Access Group - TheraCryf | FY26 results – Ox-1 programme on track

Research • 21 Aug 2026

Turner Pope Investments - Proposed Placing & Subscription to raise £1.05m

Research • 20 Aug 2026

Capital Access Group - TheraCryf | £1.1m raise progressing Ox-1 to clinical trial

Overview

TheraCryf: Turner PopeJun 3, 2025

Classification

SectorFinance

ExchangeLondon Stock Exchange